Federal contractor · public award history
EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.
DBA EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC
Parent: EMERGENT BIOSOLUTIONS INC. Unique Entity Identifier (UEI)DKEFA8JAW3X4
- Awards we know about
- 3
- Typical size
- $804.86M
- Middle of their public awards
- Dollars on those awards
- $2.31B
Most of their awards we can see fall roughly between $461.71M and $1.10B.
SAM.gov registration
- Status
- Active
- Purpose of registration
- All awards (Z2)
- Registration expires
- Oct 9, 2026
- Activation date
- Oct 13, 2025
- Primary NAICS (SAM)
- Research and Development in Biotechnology (except Nanobiotechnology)541714
Other NAICS on file
Business types (SAM)
Registration fields from the official SAM.gov public entity extract (monthly bulk). Not a substitute for live SAM checks.
Continue contractor research
Use the verified identifiers and public award record to investigate documented incumbents, compare competitors, or identify possible teaming partners. This is a research starting point, not a capability or partner recommendation.
These official USAspending contract records do not rate capability or past performance and do not tell you whether to team or bid.
Awarding agencies
- Department of Health and Human Services (3)
Industries & product codes
Award history
- Department of Health and Human Services$804.86MSep 5, 2025Procurement Instrument Identifier (PIID)75A50119C00071Biological Product (except Diagnostic) Manufacturing325414Medical And Surgical Instruments, Equipment, And Supplies6515Contract awardUSAspending ↗
ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM)
- Department of Health and Human Services$1.39BAug 29, 2025Procurement Instrument Identifier (PIID)HHSO100201600030CNorth American Industry Classification System (NAICS)541711Health R&D Services; Health Care Services; Applied ResearchAN12Contract awardUSAspending ↗
IGF::OT::IGF
- Department of Health and Human Services$118.56MJul 8, 2025Procurement Instrument Identifier (PIID)75A50123C00037Research and Development in Biotechnology (except Nanobiotechnology)541714Health R&D Services; Health Care Services; Experimental DevelopmentAN13Contract awardUSAspending ↗
MEDICAL COUNTERMEASURES (MCM) THAT CAN BE DEPLOYED IN THE EVENT OF A FILOVIRUS OUTBREAK ARE A CRUCIAL COMPONENT TO THE UNITED STATES GOVERNMENT?S (USG?S) OUTBREAK RESPONSE PLAN. BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA) IS SEEKIN
For research only. This is not legal advice, a past-performance review, or a recommendation to team or bid. Check USAspending and SAM.gov.